Oliver Cornely

Prof. Dr. Oliver Cornely serves as Professor at University Hospital Cologne (University of Cologne), holding dual leadership roles as Coordinator of the Clinical Trial Office (CTO) and Partner Site Speaker for Bonn-Cologne within Germany's national clinical trial infrastructure network spanning seven regional sites.

His research centers on infectious disease vulnerabilities in immunocompromised populations, with demonstrated expertise in pneumococcal vaccination efficacy for hemodialysis patients suffering from advanced chronic kidney disease (CKD). This work addresses critical gaps in understanding pneumonia protection duration among dialysis-dependent patients whose weakened immune systems increase susceptibility to life-threatening infections despite vaccination.

Prof. Cornely actively contributes to multi-site clinical trial coordination across Germany's partner network infrastructure, focusing on real-world vaccine performance in high-risk patient cohorts through the Clinical Trial Unit.